Hair loss due to stress and anxiety is a recognised medical concern that affects many people across the UK. When the body is under significant psychological or physical strain, hormonal changes — particularly elevated cortisol — can disrupt the normal hair growth cycle, leading to noticeable shedding weeks or months later. This article explains the biological mechanisms behind stress-related hair loss, the different types you may experience, when to seek NHS advice, how diagnosis and treatment work in the UK, and practical strategies to support long-term recovery and stress management.

How Stress and Anxiety Can Cause Hair Loss

Stress elevates cortisol, disrupting the hair growth cycle and pushing follicles into the resting phase, causing shedding two to three months after the triggering event. This process is rarely permanent and typically reverses once the stressor resolves.

Hair loss due to stress and anxiety is a well-recognised phenomenon, though the precise mechanisms are still being investigated. When the body experiences significant psychological or physiological stress, it triggers a cascade of hormonal and neurochemical changes. Elevated levels of cortisol — the body's primary stress hormone — are thought to disrupt the normal hair growth cycle, pushing a greater proportion of hair follicles prematurely into the resting (telogen) phase. This disruption can result in noticeable shedding weeks or even months after the stressful event.

Not sure if this is normal? Chat with one of our pharmacists →

Anxiety, particularly when chronic, may maintain the body in a prolonged state of heightened arousal. Sustained activation of the hypothalamic-pituitary-adrenal (HPA) axis and the sympathetic nervous system has been hypothesised to impair blood flow to the scalp, reduce nutrient delivery to follicles, and alter the local immune environment around hair roots. Research has also suggested that stress-related neuropeptides, such as substance P, may influence follicle behaviour and contribute to inflammation, though these pathways remain under investigation in humans.

It is important to note that stress-related hair loss is rarely permanent. In most cases, once the underlying stressor is addressed and the body returns to a state of equilibrium, hair regrowth occurs naturally. Common triggers include major psychosocial stressors, significant illness, surgery, and childbirth — with shedding typically becoming apparent two to three months after the event. However, the visible effects can themselves become a source of anxiety, potentially creating a self-reinforcing cycle. Understanding the biological basis of this condition can help individuals approach it with greater perspective and seek appropriate support.

For further information, the NHS Hair Loss (Alopecia) page and the Primary Care Dermatology Society (PCDS) guidance on telogen effluvium provide reliable, UK-aligned resources.

Types of Stress-Related Hair Loss Explained

Telogen effluvium is the most common stress-related hair loss, causing diffuse shedding; alopecia areata is an autoimmune condition stress may trigger; and trichotillomania is a compulsive hair-pulling behaviour linked to anxiety.

Several distinct types of hair loss are associated with stress and anxiety, each with different presentations and timescales.

Telogen effluvium is the most common form of stress-related hair loss. It occurs when a significant physical or emotional stressor causes a large number of hair follicles to enter the telogen (resting) phase simultaneously. Shedding typically becomes noticeable two to three months after the triggering event. A common and important variant is postpartum telogen effluvium, which affects many women in the months following childbirth and usually resolves without treatment. Individuals may notice:

• Increased hair on pillows, in the shower drain, or on hairbrushes

• Diffuse thinning across the scalp rather than patchy loss

• Gradual improvement once the stressor resolves

Alopecia areata is an autoimmune condition in which the immune system mistakenly attacks hair follicles, resulting in patchy hair loss. Its cause is multifactorial, and psychological stress is considered a potential trigger or exacerbating factor in genetically predisposed individuals, rather than a direct cause. Patches are typically smooth and well-defined, and the condition can occasionally progress to affect the entire scalp (alopecia totalis) or body (alopecia universalis). Further information is available via the NHS Alopecia Areata page and NICE Clinical Knowledge Summary (CKS) on alopecia areata.

Trichotillomania is a body-focused repetitive behaviour characterised by compulsive urges to pull out one's own hair, often from the scalp, eyebrows, or eyelashes. It is closely linked to anxiety, stress, and obsessive-compulsive spectrum disorders. Unlike other forms of hair loss, trichotillomania results from a behavioural pattern rather than a physiological change in the follicle itself.

It is also worth noting that androgenetic alopecia (male- or female-pattern hair loss) is the most common cause of hair loss overall and is primarily driven by genetic and hormonal factors rather than stress. Stress may worsen the appearance of androgenetic alopecia but is not its underlying cause, and it is important not to misattribute this type of loss to stress alone.

Distinguishing between these types is clinically important, as each requires a different management approach. A GP can help identify which type is present based on the pattern, history, and associated symptoms.

When to See a GP About Hair Loss

See a GP if hair loss is sudden, patchy, rapidly worsening, or accompanied by scalp symptoms, systemic illness, or significant distress, as these may indicate causes beyond stress requiring specific investigation.

Many people experiencing hair loss due to stress and anxiety may initially attribute the shedding to normal variation or seasonal change. However, there are clear circumstances in which seeking medical advice is advisable. As a general guide, you should contact your GP if:

• Hair loss is sudden, severe, or rapidly worsening

• You notice distinct bald patches rather than diffuse thinning

• Hair loss is accompanied by scalp redness, itching, scaling, or pain

• You are also experiencing fatigue, unexplained weight changes, or other systemic symptoms

• Hair loss is causing significant distress or affecting your daily functioning

• You have been pulling out your own hair and feel unable to stop

Red flags requiring prompt assessment include signs that may suggest scarring (cicatricial) alopecia — such as scalp pain, pustules, crusting, or rapidly progressive permanent loss — which requires urgent referral to an NHS dermatologist to prevent irreversible follicle damage. In children, hair loss accompanied by scalp scaling, broken hairs, or swollen lymph nodes in the neck may indicate tinea capitis (a fungal scalp infection), which requires prompt GP assessment and systemic antifungal treatment.

It is particularly important not to self-diagnose, as hair loss can result from a range of underlying medical conditions — including thyroid disorders, iron deficiency anaemia, hormonal imbalances, and autoimmune diseases — that may require specific investigation and treatment. Stress may be a contributing factor, but it is not always the sole cause.

Early assessment is also valuable because some causes of hair loss, if left untreated, can lead to more permanent follicle damage. The NHS encourages patients to seek timely advice rather than waiting to see if the problem resolves on its own, especially when hair loss is accompanied by other health concerns. Your GP is the appropriate first point of contact and can refer you to an NHS dermatologist if needed.

Diagnosis and Assessment on the NHS

GPs assess hair loss through clinical history, scalp examination, and blood tests including full blood count, thyroid function, and serum ferritin to exclude underlying medical causes before attributing loss to stress.

When you present to your GP with concerns about hair loss, they will typically begin with a thorough clinical history. This includes asking about the onset and pattern of hair loss, recent stressful life events, dietary habits, medications, family history of hair loss, and any associated symptoms. A physical examination of the scalp and hair will also be performed to assess the distribution and character of the loss. A simple pull test — gently tugging a small bundle of hairs — may be used to assess active shedding.

Blood tests are commonly requested to exclude underlying medical causes. In line with UK primary care practice, the standard initial investigations for diffuse hair loss typically include:

• Full blood count (FBC) — to check for anaemia

• Thyroid function tests (TFTs) — to rule out hypothyroidism or hyperthyroidism

• Serum ferritin — to assess iron stores

Additional tests such as vitamin D, vitamin B12, or hormonal profiles are not routinely indicated for hair loss alone, but may be requested where there are specific clinical features suggesting deficiency or endocrine dysfunction. For example, hormonal testing for polycystic ovary syndrome (PCOS) or other endocrine conditions would typically be guided by features such as irregular periods, hirsutism, or acne, rather than hair loss in isolation.

If alopecia areata is suspected, the GP may refer to an NHS dermatologist for further evaluation. In some cases, a scalp biopsy may be recommended to examine follicle structure under a microscope. Dermoscopy (trichoscopy) of the scalp may be available in some primary care settings, though specialist trichoscopy is more commonly performed in dermatology clinics.

NICE guidance does not currently provide a dedicated pathway specifically for stress-related hair loss, but the NICE CKS on alopecia areata and PCDS guidance on diffuse hair loss inform best practice in primary care. A holistic assessment — addressing both physical and psychological factors — is considered good clinical practice.

Treatment and Management Options Available in the UK

Telogen effluvium often requires no treatment beyond resolving the stressor; alopecia areata may be managed with corticosteroids or specialist therapies; trichotillomania is treated with CBT and habit reversal training.

Treatment for hair loss due to stress and anxiety depends on the underlying type and any identified contributing factors. In many cases of telogen effluvium, no specific medical treatment is required, as hair regrowth occurs naturally once the stressor is resolved and any confirmed nutritional deficiencies are corrected. However, several options may be considered depending on the clinical picture.

For telogen effluvium:

• Addressing confirmed nutritional deficiencies through dietary changes or supplementation (for example, iron or vitamin D where blood tests confirm a deficit). Routine supplementation without a confirmed deficiency is not recommended.

• Reviewing any medications that may contribute to hair loss — certain antidepressants, beta-blockers, and hormonal contraceptives have been associated with shedding. Always discuss with your prescriber before making any changes to prescribed medicines. If you suspect a medicine is causing hair loss, you can report this to the MHRA via the Yellow Card scheme at yellowcard.mhra.gov.uk.

For alopecia areata:

• Topical or intralesional corticosteroids are commonly used to suppress the localised immune response and are typically initiated or supervised by a dermatologist.

• Topical minoxidil may support regrowth in some individuals; however, its use in alopecia areata is off-label (it is licensed in the UK for androgenetic alopecia), and it should only be used following discussion with a clinician.

• For extensive or severe alopecia areata, specialist therapies such as contact immunotherapy (e.g., diphencyprone, DPCP) may be available in specialist dermatology centres.

• JAK inhibitors represent a newer treatment option for severe alopecia areata. Ritlecitinib (Litfulo) has received a NICE Technology Appraisal (2024) for severe alopecia areata in people aged 12 years and over in England, subject to specific eligibility criteria. Baricitinib holds a licence for severe alopecia areata in adults in Great Britain; patients and clinicians should check current NICE appraisal and NHS commissioning status for the latest guidance. These medicines are specialist-initiated, require monitoring, and carry important safety considerations including risks of serious infection and venous thromboembolism (VTE); full prescribing information is available via the MHRA/EMC SmPC. Brand names are not used here to avoid promotional framing.

For trichotillomania:

• Psychological therapies, particularly habit reversal training (HRT) and cognitive behavioural therapy (CBT), are the recommended first-line treatments.

• Referral to NHS Talking Therapies (in England) may be appropriate for anxiety management.

Many over-the-counter hair growth products make claims that are not supported by robust clinical evidence. Patients should exercise caution and discuss any supplements or topical treatments with their GP or pharmacist before use. In particular, high-dose biotin supplementation is not recommended without a confirmed deficiency, as it can interfere with certain laboratory tests including thyroid function tests and cardiac troponin assays.

Supporting Recovery and Reducing Stress Long-Term

Long-term recovery involves regular exercise, adequate sleep, balanced nutrition, and evidence-based psychological support such as NHS Talking Therapies CBT, with organisations like Mind and Alopecia UK offering additional peer support.

Addressing the root cause of stress and anxiety is central to supporting hair recovery and preventing recurrence. Long-term stress management is not simply beneficial for hair health — it has wide-ranging positive effects on cardiovascular, immune, and mental wellbeing. A sustainable approach to reducing stress typically involves a combination of lifestyle modifications, psychological support, and, where appropriate, professional intervention.

Practical strategies that may help include:

• Regular physical activity — exercise has well-established benefits for reducing cortisol levels and improving mood

• Adequate sleep — poor sleep quality exacerbates stress responses and impairs tissue repair, including follicle recovery

• Balanced nutrition — a diet rich in protein, iron, zinc, and vitamins C, D, and E supports healthy hair growth. It is important to obtain these through a varied, balanced diet where possible. Supplementation should only be used to correct confirmed deficiencies. Note that excessive vitamin A intake (through high-dose supplements) can itself cause hair loss and should be avoided.

• Mindfulness and relaxation techniques — practices such as mindfulness-based stress reduction (MBSR), yoga, and breathing exercises have evidence supporting their role in anxiety management

• Gentle hair care — avoiding excessive heat styling, tight hairstyles (traction), and harsh chemical treatments can help minimise additional mechanical stress on fragile hair

For those whose anxiety is persistent or significantly impairing daily life, NHS Talking Therapies offers free access to CBT and other evidence-based psychological treatments for people in England; you can self-refer in most areas or ask your GP for a referral. Pathways differ in Scotland, Wales, and Northern Ireland — your GP can advise on locally available services. Charitable organisations such as Mind, Anxiety UK, and Alopecia UK also provide valuable resources and peer support.

In some circumstances, NHS services may be able to provide access to cosmetic support such as wigs or scalp camouflage products; eligibility varies by local service, and your GP or dermatologist can advise.

Finally, it is worth acknowledging that hair loss itself can be emotionally distressing, and feelings of self-consciousness or low confidence are entirely valid. Seeking support for the psychological impact of hair loss — not just the physical symptoms — is an important part of holistic recovery. With appropriate care and time, the outlook for stress-related hair loss is generally positive.

Frequently Asked Questions